Alzamend Neuro, Inc. - 8-K Filing
Alzamend Neuro pauses Bipolar Disorder clinical trial following negative FDA feedback and terminates Statement of Work with Massachusetts General Hospital.
Tickers: $ALZN
Alzamend Neuro pauses Bipolar Disorder clinical trial following negative FDA feedback and terminates Statement of Work with Massachusetts General Hospital.
Tickers: $ALZN